Evidence map›Paper›PMID 41583190›Full record

ArticleCureus2025

A Prospective Observational Study on the Clinical and Microbiological Profile of Catheter-Related Blood Stream Infections in Hemodialysis Patients and Their Outcome in a Tertiary Care Centre in Northeast India.

Gayatri Pegu, Angelia L Khawbung, Manjuri Sharma, Prodip K Doley, Miranda Pegu

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gayatri PeguDepartment of Nephrology, Gauhati Medical College and Hospital, Guwahati, IND.
Angelia L KhawbungDepartment of Nephrology, Gauhati Medical College and Hospital, Guwahati, IND.
Manjuri SharmaDepartment of Nephrology, Gauhati Medical College and Hospital, Guwahati, IND.
Prodip K DoleyDepartment of Nephrology, Gauhati Medical College and Hospital, Guwahati, IND.
Miranda PeguDepartment of Nephrology, Gauhati Medical College and Hospital, Guwahati, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCatheter-related bloodstream infections (CRBSIs) are major complications for hemodialysis patients dependent on central venous catheters (CVCs). Variations in infection control practices and prolonged catheter use amplify the risk and lead to increased morbidity, mortality, and healthcare costs.

objectivesThis study aimed to determine the clinical and microbiological profile of CRBSIs in hemodialysis patients and to assess the outcomes, including in-hospital mortality. METHODOLOGY: This prospective observational study was conducted in the Department of Nephrology, Gauhati Medical College, in Guwahati, Assam, India, from May 2024 to April 2025. A total of 67 adult patients (≥18 years) undergoing maintenance hemodialysis with tunneled or non-tunneled CVCs and clinically suspected CRBSIs were enrolled. CRBSI was defined using the Centers for Disease Control and Prevention (CDC) and Infectious Diseases Society of America (IDSA) criteria. Patients with alternative identifiable infection sources or incomplete microbiological data were excluded. Baseline demographics, comorbidities, clinical presentation, laboratory parameters, catheter characteristics, microbiological profile, treatment, and in-hospital outcomes were obtained from medical records using a standardized data collection form. Blood cultures were obtained aseptically prior to antibiotic initiation, including paired peripheral and catheter-drawn samples. Samples were processed using the BACTEC system, and organism identification was performed using the VITEK 2 system in accordance with standard microbiological protocols. CRBSI incidence was calculated as episodes per 1,000 catheter-days. Clinical outcomes assessed included catheter removal, length of hospital stay, and all-cause in-hospital mortality. Continuous variables were expressed as mean ± standard deviation or median (interquartile range), and categorical variables as frequencies and percentages. Univariate comparisons were performed using Student's t-test for continuous variables and Chi-square or Fisher's exact test for categorical variables, as appropriate. Variables with a p-value <0.10 on univariate analysis were entered into the multivariate logistic regression model. A p-value <0.05 was considered statistically significant. Statistical analyses were performed using IBM SPSS Statistics.

resultsThe mean age was 48.2 ± 12.8 years, and 62.7% of patients were male. Diabetes and hypertension were the leading causes of end-stage kidney disease (ESKD) (44.8%), indicating a high-risk cohort with prolonged catheter exposure. Total catheter exposure was 6,645 days, with a CRBSI incidence of 10.08 episodes per 1,000 catheter-days. Blood cultures were positive in 74.6% of cases, yielding Gram-positive cocci (34.8%), Gram-negative bacilli (39.0%), and fungi (1.5%), while 25.4% remained culture-negative. In-hospital mortality was 31.3%. Non-survivors showed higher rates of Gram-negative infection (55.0% vs. 36.2%; p = 0.04) and culture positivity (85.0% vs. 70.2%; p = 0.08). Median catheter dwell time was similar between groups (1.5 months each; p = 0.17).

conclusionThe observed CRBSI incidence and mortality exceeded rates reported in high-resource settings. Early arteriovenous fistula creation, strict adherence to aseptic protocols, and empiric antimicrobial regimens covering both Gram-positive and Gram-negative organisms are urgently required.

Indexed as

catheter-dayscatheter-related bloodstream infectioncentral venous cathetergram-negative bacilliincidencemortality

Identifiers

PMID41583190
PMCPMC12830062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.